the aid library

LIST OPTIONS

Filter

2439

Download (791)

View PDF (780)

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWID- Male) in Western to Far Western Terai Highway Districts of Nepal, Round V, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1

Download (2401)

View PDF (1910)

Nepal: National Guidelines on Case Management of Sexually Transmitted Infections
recommended

Government of Nepal Ministry of Health and Population Department of Health Services, National Centre for AIDS and STD Control (2014) C1

Download (448)

View PDF (621)

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users in Kathmandu Valley, Round I, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1

Download (878)

View PDF (1110)

The National Guidelines for the Management of HIV and AIDS in Children in Nepal

Government of Nepal, Ministry of Health and Population, National Centre for AIDS and STD Control (2008) CC

Download (119)

View PDF (156)

National violence prevention and response protocol

Ministry of Health, Kenya; National AIDS Control Council (2017) C1

A Meand to enhancing HIV prevention in key populations. This document has been developed out of the increasing need to set up standards and procedures to prevent and respond to violence against key populations.

Download (542)

View PDF (739)

Integrated Biological and Behavioral Surveillance Survey among Female Sex Workers in the 22 Highway Districts of Nepal, Round VI, 2016

Ministry of Health Nepal; National Center for AIDS and STD Control (NCASC) (2016) C1

Download (391)

View PDF (799)

State Epidemiological Fact Sheets – Volume 3, Northern, Central & Eastern Region

Government of India, Ministry of Health and Family Welfare, National AIDS Control Organisation (NACO) (2017) C1

Northern: Chandigarh, Delhi, Haryana, Himachal Pradesh, Jammu & Kashmir, Punjab, Rajasthan, and Uttarakhand
Central: Chhattisgarh, Madhya Pradesh and Uttar Pradesh
Eastern: Andaman & Nicobar, Bihar, Jharkhand, Odisha and West Bengal
This technical document consists of epidemiological ... more

Download (3455)

View PDF (843)

Philippine Health Advisories

Department of Health, National Center for Health Promotion, National Center for Disease Prevention and Control (2012) C1

Download (848)

View PDF (1725)

Questions and Answers About Tuberculosis
recommended

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, Centers for Disease Control and Prevention (2014) C_CDC

Download (350)

View PDF (736)

State Epidemiological Fact Sheets – Volume 2, West & South Regions

Government of India, Ministry of Health and Family Welfare, National AIDS Control Organisation (NACO) (2017) C1

West: Drada & Nagar Haveli, Daman & Diu, Goa, Gujarat, Maharashtra
South: Andhra Pradesh & Telangana, Karnataka, Kerala, Puducherry, Tamil Nadu
This technical document consists of epidemiological profiles (fact-sheets) for States and districts based on information available from multiple d... more

Download (847)

View PDF (1707)

A global brief on vector-borne diseases

World Health Organization (2014) C_WHO

With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended

World Health Organization WHO (2023) C_WHO

2nd edition. This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygiene services to underserved population affected by many neglected tropical diseases. The ... more

Download (2588)

View PDF (1624)

Reproductive, Maternal, Newborn, and Child Health

Robert E. Black, Ramanan Laxminarayan, Marleen Temmerman; et al. International Bank for Reconstruction and Development The World Bank (2016) CC

Disease Control Priorities –3rdEdition, Volume 2. This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and ... more

Download (160)

View PDF (198)

Global Programme to Eliminate Lymphatic Filariasis

World Health Organization WHO (2013) C_WHO

The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und... more

Download (2935)

View PDF (2019)

WHO Guidelines for malaria
recommended

World Health Organization (WHO) (2022) C_WHO

25 Nov 2022 The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform. The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment of mala... more

Download (173)

View PDF (191)

Protocol for assessment of potential risk factors for 2019-novel coronavirus (2019-nCoV) infection among health care workers in a health care setting
recommended

World Health Organization WHO (2020) C_WHO

This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level... more

Download (54)

View PDF (42)

The Trachoma End Game: The Power of Persistence, Partnership, and Passion

The Carter Center (2023) CC

Twenty-Fourth Annual Trachoma Control Program Review, Summary Proceedings

Download (2018)

View PDF (1884)

Cancer
recommended

Hellen Gelband,Jha Prabhat, Rengaswamy Sankaranarayanan et al. The World Bank (2015) C1

This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte... more

Download (164)

View PDF (185)

Nigeria: Yellow Fever DREF Operation n° MDRNG031 Final Report

The International Federation of Red Cross and Red Crescent Societies IFRC (2021) CC

The Nigeria Centre for Disease Control (NCDC) declared a Yellow Fever (YF) outbreak and activated a multi-sectoral Emergency Operations Centre for coordination of Yellow Fever response on 12 November 2020. The outbreak, which mainly affected three states of Delta, Enugu and Bauchi, already recorded ... more

Nepal: National Guidelines on Case Management of Sexually Transmitted Infections recommended

Questions and Answers About Tuberculosis recommended

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes recommended

WHO Guidelines for malaria recommended

Protocol for assessment of potential risk factors for 2019-novel coronavirus (2019-nCoV) infection among health care workers in a health care setting recommended

Cancer recommended